ArticleBone marrow transplantation2013

Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALL.

J Sanchez-Garcia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.